12,372 trials
Chronic Hepatitis C
Primary: Percentage of Participants Achieving Sustained Viral Response 12 Weeks After Completing Study Therapy (SVR12) — 90.0; 100.0 Percentage of participants
Atherosclerotic Lesion(s)
Primary: In-stent Late Loss — 0.23 mm
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Percentage of Participants Reporting Safety and Tolerability in Terms of Adverse Event (AE) Reporting Rate — 77.3; 77 Percentage of participants
Bacterial Infections · Virus Diseases
Primary: Percentage of Participants Responding to Polyribosylribitol Phosphate Antigen — 84.97; 75.39; 97.25; 92.41 Percentage of participants — p=<0.001
Prostate Cancer
Primary: Overall Survival (OS) — 11.04; 10.02 months — p=0.0127
Lesion of Stomach
Primary: Total Cumulative Mucosal Visibility Score — 5.78; 8.89 units
Major Depressive Disorder · Irritability
Primary: Change From Baseline to Week 6 in SIS Total Score — -21.13 units on a scale
Non-Small Cell Lung Cancer
Primary: Progression-free Survival (PFS) — 3.7; 4.8 months — p=0.0006
Anemia
Primary: Percentage of Participants Who Maintained Average Hb Within Plus/Minus (±) 1 g/dL of Reference Hb and Within Target Range During the Efficacy Evaluation Period (EEP)…
Heart Transplantation · Liver Transplantation · Kidney Transplantation
Primary: Participant Survival — 0.9092; 1.0000; 0.9356; 0.9031 survival probability
Lupus Erythematosus, Systemic
Primary: Percentage of Participants Experiencing a New Flare as Defined by British Isles Lupus Assessment Group (BILAG) Score A or B — 57.32; 36.11; 53.25 percentage of…
Venous Leg Ulcers
Primary: Compare the Treatment Groups for the Proportion of Subjects With Complete Wound Closure Over the 12-Week Treatment Period From Baseline — 129; 126; 82; 84 participants…
Cytomegalovirus Retinitis · HIV Infections
Primary: Survival — 31; 30 participants
Refractory Migraine
Primary: Mean Number of Days of Decrease in Pain Level Using VAS — 1.20; 8.67 days — p=0.0347
Lateral Canthal Lines · Crow's Feet Lines
Primary: Percentage of Subjects Achieving None or Mild on the Investigator's Assessment of the Severity of Crow's Feet Lines (CFL) at Maximum Smile Using the Facial Wrinkle…